The trends we’ve explored paint a future where innovation is a tangible reality driving the sector forward.
As we look toward 2024, the biotech industry’s landscape is undeniably vibrant and brimming with potential. The trends we’ve explored paint a future where innovation is a tangible reality driving the sector forward. The resurgence of M&A activities, the profound impact of AI, and the burgeoning advances in RNA technology, CRISPR, bioprinting, tissue engineering, stem cell research, and targeted protein degradation, all represent significant strides in the industry.